CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV)
CUSIP: 18914F103
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 416,598,522
- Total 13F shares
- 73,223,084
- Share change
- -15,939,650
- Total reported value
- $90,062,636
- Put/Call ratio
- 71%
- Price per share
- $1.23
- Number of holders
- 121
- Value change
- -$13,953,079
- Number of buys
- 48
- Number of sells
- 66
Quarterly Holders Quick Answers
What is CUSIP 18914F103?
CUSIP 18914F103 identifies CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 18914F103:
Top shareholders of CLOV - CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Chamath Palihapitiya |
3/4/5
|
FORMER CHIEF EXECUTIVE OFFICER AND DIRECTOR, 10%+ Owner |
—
class O/S missing
|
30,147,610
|
$29,544,657 | — | 07 Jul 2021 | |
| GREENOAKS CAPITAL PARTNERS LLC |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
25,754,556
|
$24,466,828 | — | 22 Nov 2021 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
17,698,654
|
$14,052,732 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.7%
|
11,396,600
|
$9,049,000 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.5%
|
10,580,658
|
$8,401,042 | — | 31 Mar 2024 | |
| Scott J. Leffler |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
4,857,303
|
$4,760,157 | — | 25 Jan 2024 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
1.2%
|
5,110,666
|
$4,057,869 | — | 31 Mar 2024 | |
| JUPITER ASSET MANAGEMENT LTD |
13F
|
Company |
1.1%
|
4,525,079
|
$3,592,913 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1%
|
4,301,558
|
$3,416,308 | — | 31 Mar 2024 | |
| CLOVER HEALTH INVESTMENTS, CORP. /DE |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
3,093,225
|
$3,031,361 | — | 31 Oct 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.89%
|
3,718,177
|
$2,952,233 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.87%
|
3,621,025
|
$2,875,094 | — | 31 Mar 2024 | |
| Joseph R. Martin |
3/4/5
|
General Counsel |
—
class O/S missing
|
2,718,857
|
$2,664,480 | — | 14 Jun 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.74%
|
3,094,125
|
$2,456,735 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.61%
|
2,525,895
|
$2,005,561 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.58%
|
2,427,496
|
$1,927,432 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.53%
|
2,227,547
|
$1,768,672 | — | 31 Mar 2024 | |
| Nathaniel S. Turner |
3/4/5
|
Director |
—
class O/S missing
|
1,324,728
|
$1,258,492 | — | 07 Jan 2021 | |
| Invesco Ltd. |
13F
|
Company |
0.32%
|
1,330,140
|
$1,056,132 | — | 31 Mar 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.31%
|
1,305,200
|
$1,036,329 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.29%
|
1,196,831
|
$950,284 | — | 31 Mar 2024 | |
| Prabhdeep Singh |
3/4/5
|
Chief Growth Officer |
—
class O/S missing
|
872,821
|
$855,365 | — | 16 Sep 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.21%
|
868,542
|
$689,622 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.2%
|
840,835
|
$667,623 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.2%
|
813,788
|
$646,148 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.19%
|
784,472
|
$622,871 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.18%
|
763,000
|
$605,822 | — | 31 Mar 2024 | |
| Swiss National Bank |
13F
|
Company |
0.18%
|
743,300
|
$590,180 | — | 31 Mar 2024 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.17%
|
697,418
|
$553,749 | — | 31 Mar 2024 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.16%
|
652,990
|
$518,474 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.15%
|
618,908
|
$491,413 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.11%
|
468,335
|
$371,858 | — | 31 Mar 2024 | |
| State of Wyoming |
13F
|
Company |
0.11%
|
460,358
|
$365,524 | — | 31 Mar 2024 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.1%
|
407,395
|
$323,472 | — | 31 Mar 2024 | |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM |
13F
|
Company |
0.08%
|
341,324
|
$271,011 | — | 31 Mar 2024 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.07%
|
307,728
|
$244,000 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.07%
|
284,737
|
$226,082 | — | 31 Mar 2024 | |
| STATE OF WISCONSIN INVESTMENT BOARD |
13F
|
Company |
0.07%
|
282,808
|
$224,550 | — | 31 Mar 2024 | |
| SAGE RHINO CAPITAL LLC |
13F
|
Company |
0.06%
|
261,500
|
$207,631 | — | 31 Mar 2024 | |
| Legal & General Group Plc |
13F
|
Company |
0.06%
|
254,652
|
$202,193 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.06%
|
242,492
|
$192,540 | — | 31 Mar 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.06%
|
238,178
|
$188,775 | — | 31 Mar 2024 | |
| TRUIST FINANCIAL CORP |
13F
|
Company |
0.04%
|
181,884
|
$144,416 | — | 31 Mar 2024 | |
| FreeGulliver LLC |
13F
|
Company |
0.04%
|
180,000
|
$142,920 | — | 31 Mar 2024 | |
| Bayesian Capital Management, LP |
13F
|
Company |
0.04%
|
179,000
|
$142,126 | — | 31 Mar 2024 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.04%
|
178,934
|
$142,000 | — | 31 Mar 2024 | |
| Point72 Asia (Singapore) Pte. Ltd. |
13F
|
Company |
0.04%
|
172,158
|
$136,693 | — | 31 Mar 2024 | |
| Turtle Creek Wealth Advisors, LLC |
13F
|
Company |
0.04%
|
170,000
|
$134,980 | — | 31 Mar 2024 | |
| VOYA INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
163,124
|
$129,520 | — | 31 Mar 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.04%
|
154,963
|
$123,041 | — | 31 Mar 2024 |
Institutional Holders of CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) as of Q2 2024
As of 30 Jun 2024,
CLOVER HEALTH INVESTMENTS, CORP. /DE - Common Stock (CLOV) was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
73,223,084 shares.
The largest 10 holders included
VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., PNC Financial Services Group, Inc., GEODE CAPITAL MANAGEMENT, LLC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Qube Research & Technologies Ltd, CITADEL ADVISORS LLC, and TWO SIGMA INVESTMENTS, LP.
This page lists
122
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
132
Q2 2024 holders
121
Holder diff
-11
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.